Michael Davidson to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Michael Davidson has written about Xenograft Model Antitumor Assays.
Connection Strength
0.029
-
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 2018 10; 67(10):1780-1792.
Score: 0.029
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.